Public Market Listing
2511HKEX
Live quotes, historical charts, and market capitalization for HighTide Biopharma are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | AMPK pathway / NLRP3 inflammasome (dual)Small molecule | Type 2 DiabetesAtherosclerotic Cardiovascular Disease |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Regulatory and conference events
(2)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent
8 June 2026Filing acceptedBerberine ursodeoxycholate (HTD1801)HTD1801 NDA accepted for review by China NMPA
CN, NMPA · Source ↗
Financial reports
No financial reports recorded.